UNIGE document Scientific Article - Review
previous document  unige:44929  next document
add to browser collection

Nouveautés en médecine 2006 : Psychiatrie

Delini-Stula, A
Published in Revue médicale suisse. 2007, vol. 3, no. 94, p. 161-7
Abstract Introduced this year on the Swiss market, duloxetine (Cymbalta) is a new antidepressant which inhibits the reuptake of noradrenaline and serotonin. Clinical studies have shown its efficacy in depression as well as in neuropathic pains (60-120 mg/day) with a good tolerability. In this paper are also included short reviews about the two large American studies developed by the National Institute of Mental Health in the fields of the treatment for depression (STAR-D) and of the antipsychotic treatments for schizophrenia (CATIE study). Its also reviews two questions of present interest: the use of the second generation antipsychotics for the treatment of bipolar depression and the concept of bipolar disorders in children.
Keywords AdolescentAntidepressive Agents/therapeutic useBipolar Disorder/drug therapyChildDepression/drug therapyHumansMental Disorders/drug therapySchizophrenia/drug therapyThiophenes/therapeutic use
PMID: 17354543
Full text
Article (Published version) (75 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Article (Published version) (2.8 MB) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://www.revmed.ch/rms/2007/RMS-94/31885
Research group Groupe Ansermet François (psychiatrie) (861)
(ISO format)
AUBRY, Jean-Michel et al. Nouveautés en médecine 2006 : Psychiatrie. In: Revue médicale suisse, 2007, vol. 3, n° 94, p. 161-7. https://archive-ouverte.unige.ch/unige:44929

372 hits



Deposited on : 2015-01-12

Export document
Format :
Citation style :